Literature DB >> 17990224

Pneumococcal carriage among indigenous Warao children in Venezuela: serotypes, susceptibility patterns, and molecular epidemiology.

Ismar A Rivera-Olivero1, Debby Bogaert, Teresita Bello, Berenice del Nogal, Marcel Sluijter, Peter W M Hermans, Jacobus H de Waard.   

Abstract

Little attention has been paid to pneumococcal carriage and disease in Amerindians from Latin America. The Warao people, an indigenous population from Venezuela, live in the delta of the Orinoco River in geographically isolated communities with difficult access to medical care. To obtain insight into pneumococcal carriage and the theoretical coverage of pneumococcal vaccines in this population, we investigated pneumococcal colonization, serotype, and genotype distribution among Warao children in 9 distinct, geographically isolated communities in the Delta Amacuro area in the northeast of Venezuela. From April 2004 through January 2005, a total of 161 Streptococcus pneumoniae isolates were recovered from single nasopharyngeal swab samples obtained from 356 children aged 0-72 months. The overall pneumococcal carriage rate was 49%, ranging from 13% to 76%, depending on the community investigated and the age of the children (50% among children aged <2 years and 25% among children aged >2 years). The most frequent serotypes were 23F (19.5% of isolates), 6A (19.5%), 15B (10.4%), 6B (9.1%), and 19F (7.2%). The theoretical coverage of the 7-valent pneumococcal conjugate vaccine, including the cross-reactive nonvaccine serotype 6A, was 65%. A total of 26% of the isolates were resistant to first-line antibiotics, with 70% of these strains being covered by the 7-valent pneumococcal conjugate vaccine. Restriction fragment end labelling analysis revealed 65 different genotypes, with 125 (80%) of the isolates belonging to 27 different genetic clusters, suggesting a high degree of horizontal spread of pneumococcal strains in and between the villages. The high colonization rates and high (registered) acute respiratory tract infection morbidity and mortality in this part of Venezuela suggest that Warao children are at increased risk for pneumococcal disease and, therefore, benefit from vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17990224     DOI: 10.1086/522984

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage.

Authors:  I A Rivera-Olivero; B del Nogal; M C Sisco; D Bogaert; P W M Hermans; J H de Waard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

2.  Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

Authors:  B Quintero; M Araque; C van der Gaast-de Jongh; F Escalona; M Correa; S Morillo-Puente; S Vielma; P W M Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-30       Impact factor: 3.267

Review 3.  Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Authors:  Elizabeth Castañeda; Clara Inés Agudelo; Rodrigo De Antonio; Diego Rosselli; Claudia Calderón; Eduardo Ortega-Barria; Rómulo E Colindres
Journal:  BMC Infect Dis       Date:  2012-05-28       Impact factor: 3.090

4.  Low child survival index in a multi-dimensionally poor Amerindian population in Venezuela.

Authors:  Julian A Villalba; Yushi Liu; Mauyuri K Alvarez; Luisana Calderon; Merari Canache; Gaudymar Cardenas; Berenice Del Nogal; Howard E Takiff; Jacobus H De Waard
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010.

Authors:  Miwako Kobayashi; Laura M Conklin; Godfrey Bigogo; Geofrey Jagero; Lee Hampton; Katherine E Fleming-Dutra; Muthoni Junghae; Maria da Gloria Carvalho; Fabiana Pimenta; Bernard Beall; Thomas Taylor; Kayla F Laserson; John Vulule; Chris Van Beneden; Lindsay Kim; Daniel R Feikin; Cynthia G Whitney; Robert F Breiman
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

6.  Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.

Authors:  Martin O C Ota; Anna Roca; Christian Bottomley; Philip C Hill; Uzochukwu Egere; Brian Greenwood; Richard A Adegbola
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

7.  Population biology of Streptococcus pneumoniae in West Africa: multilocus sequence typing of serotypes that exhibit different predisposition to invasive disease and carriage.

Authors:  Eric S Donkor; Richard A Adegbola; Brendan W Wren; Martin Antonio
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

8.  Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.

Authors:  Ifedayo M O Adetifa; Martin Antonio; Christy A N Okoromah; Chinelo Ebruke; Victor Inem; David Nsekpong; Abdoulie Bojang; Richard A Adegbola
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

9.  High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Authors:  Deirdre A Collins; Anke Hoskins; Jacinta Bowman; Jade Jones; Natalie A Stemberger; Peter C Richmond; Amanda J Leach; Deborah Lehmann
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

10.  High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction.

Authors:  Laura M Conklin; Godfrey Bigogo; Geofrey Jagero; Lee Hampton; Muthoni Junghae; Maria da Gloria Carvalho; Fabiana Pimenta; Bernard Beall; Thomas Taylor; Brian Plikaytis; Kayla F Laserson; John Vulule; Chris Van Beneden; Cynthia G Whitney; Robert F Breiman; Daniel R Feikin
Journal:  BMC Infect Dis       Date:  2016-01-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.